Delivery Order SPE2DX22D0010-SPE2D826FAV24
- Not listed
- This delivery order, awarded October 27, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The $130,923.54 firm fixed-price delivery order was competitively awarded with no set-aside designation to support the Defense Department's Medical Supply Chain. AmerisourceBergen, headquartered in Conshohocken,...
- This delivery order, awarded November 3, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $66,834.18 firm fixed-price delivery order was issued by the Medical Supply Chain, a defense-focused federal agency, with performance in AmerisourceBergen's Conshohocken, Pennsylvania corporate headquarters. As a non-set-aside competitive award, this delivery order leverages...
- This delivery order, awarded on October 16, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order is valued at $874,612.30 on a firm fixed-price basis with an ultimate completion date of October 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was competitively awarded this contract...
- This delivery order, awarded September 1, 2025, represents a child contract under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $255,145.60 firm fixed price delivery order is funded through the Medical Supply Chain, a defense agency component, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competitively...
- This delivery order, awarded on October 16, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The $15,967.84 firm fixed-price delivery order was competitively awarded with no set-aside designation to supply pharmaceutical products and medical supplies to support federal medical procurement needs....
- This delivery order, awarded June 27, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 through December 2026. The current delivery order carries a ceiling value of $190,538.53 with a firm fixed price structure and an ultimate completion date of June 30, 2025. The award was made without set-aside designation through competitive procurement to...
- This delivery order, awarded on September 29, 2025, represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at approximately $36.1K with a firm fixed price structure, supports the federal government's pharmaceutical and medical supply procurement needs through the Medical Supply Chain, a defense-oriented federal agency. AmerisourceBergen Drug Corp, a major...
- This delivery order, awarded on September 11, 2025, represents a child contract under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999.99 million through December 2026. The specific delivery order carries a ceiling value of $4,900.32 and operates under firm fixed-price terms with no set-aside designation, indicating competitive award. The contract is funded by the Medical Supply Chain, a...
- This delivery order, awarded on September 18, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is valued at $792,825.94 under firm fixed pricing with an ultimate completion date of September 19, 2025. The award was made through open competition with no set-aside designation to AmerisourceBergen Drug Corp,...
- This delivery order, awarded on September 10, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,218.87 with a firm fixed price structure, was competitively awarded without a set-aside designation to support the Medical Supply Chain, a defense-focused federal agency. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAV24Delivery Order
This delivery order, awarded November 4, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The $79,394.67 delivery order was issued by the Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement for military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The award utilized firm fixed pricing with no set-aside designation, reflecting competitive award principles consistent with the company's established federal procurement track record. Under this delivery order, AmerisourceBergen will supply pharmaceutical products and medical supplies to support military healthcare programs, drawing from the comprehensive portfolio available under its prime IDC. The company's federal contract history demonstrates expertise in delivering diverse medical commodities including brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains. With an ultimate completion date of November 5, 2025, and performance location at the corporate office in Conshohocken, Pennsylvania, this delivery order continues AmerisourceBergen's role as a key supplier within the DLA's Pharmaceutical Prime Vendor Global Program infrastructure supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $79.4k | 11/4/25 |